Evidence map›Paper›PMID 35029639›Full record

ArticleThe Biochemical journal2022

IKKα plays a major role in canonical NF-κB signalling in colorectal cells.

Jack A Prescott, Kathryn Balmanno, Jennifer P Mitchell, Hanneke Okkenhaug, Simon J Cook

Open access · hybridAbstract read
In one paragraph

Article in The Biochemical journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. The roles of IKKα in normal physiology and cancer.Cell communication and signaling : CCS · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Targeted Treatment against Cancer Stem Cells in Colorectal Cancer.International journal of molecular sciences · 2024
    Review
  15. Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jack A PrescottSignalling Programme, The Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, U.K.
Kathryn BalmannoSignalling Programme, The Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, U.K.
Jennifer P MitchellSignalling Programme, The Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, U.K.
Hanneke OkkenhaugImaging Facility, The Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, U.K.
Simon J CookSignalling Programme, The Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, U.K.ORCID 0000-0001-9087-1616
Babraham Institute · GB

Funding

Biotechnology and Biological Sciences Research Council BB/P013384/1Biotechnology and Biological Sciences Research Council BB/S017062/1
6 · The paper itself

Abstract

Inhibitor of kappa B (IκB) kinase β (IKKβ) has long been viewed as the dominant IKK in the canonical nuclear factor-κB (NF-κB) signalling pathway, with IKKα being more important in non-canonical NF-κB activation. Here we have investigated the role of IKKα and IKKβ in canonical NF-κB activation in colorectal cells using CRISPR-Cas9 knock-out cell lines, siRNA and selective IKKβ inhibitors. IKKα and IKKβ were redundant for IκBα phosphorylation and turnover since loss of IKKα or IKKβ alone had little (SW620 cells) or no (HCT116 cells) effect. However, in HCT116 cells IKKα was the dominant IKK required for basal phosphorylation of p65 at S536, stimulated phosphorylation of p65 at S468, nuclear translocation of p65 and the NF-κB-dependent transcriptional response to both TNFα and IL-1α. In these cells, IKKβ was far less efficient at compensating for the loss of IKKα than IKKα was able to compensate for the loss of IKKβ. This was confirmed when siRNA was used to knock-down the non-targeted kinase in single KO cells. Critically, the selective IKKβ inhibitor BIX02514 confirmed these observations in WT cells and similar results were seen in SW620 cells. Notably, whilst IKKα loss strongly inhibited TNFα-dependent p65 nuclear translocation, IKKα and IKKβ contributed equally to c-Rel nuclear translocation indicating that different NF-κB subunits exhibit different dependencies on these IKKs. These results demonstrate a major role for IKKα in canonical NF-κB signalling in colorectal cells and may be relevant to efforts to design IKK inhibitors, which have focused largely on IKKβ to date.

Indexed as

Colorectal NeoplasmsCRISPR-Cas SystemsGene Knockout TechniquesHCT116 CellsHumansI-kappa B KinaseInterleukin-1alphaNF-kappa BNF-KappaB Inhibitor alphaPhosphorylationProtein Kinase InhibitorsRNA, Small InterferingSignal TransductionTransfectionTumor Necrosis Factor-alphaCHUK protein, humanI-kappa B KinaseIKBKB protein, humanIL1A protein, humanInterleukin-1alphaNF-kappa BNF-KappaB Inhibitor alphaProtein Kinase InhibitorsRNA, Small InterferingTNF protein, humanTumor Necrosis Factor-alphacolorectal cancer cellsIKKβIL-1NF-κBTNF

Identifiers

PMID35029639
PMCPMC8883499
OpenAlexW4206037495

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.